Shares of Aurora Cannabis (NYSE:ACB,TSX:ACB) continued to take a beating on Monday (November 18) after the firm announced it is halting the construction of two of its planned facilities to save a total of C$190 million.

Aurora has dropped 29.9 percent since market close on Thursday (November 14), the day it released its most recent quarterly results; it sat at C$3.07 as of 2:44 p.m. EST on Monday.


In its results for its first fiscal quarter of 2020, the Edmonton-based company confirmed it will be stopping construction of its Aurora Nordic 2 facility in Denmark to save C$80 million over the next year.

The company also said it will be indefinitely deferring construction of its Aurora Sun facility in Medicine Hat, Alberta, and will conserve C$110 million in the process.

Aurora Sun was slated to be a 1.2 million square foot facility in the firm’s home province when it was first announced in 2018, and would have brought Aurora’s yearly cultivation capacity to 430,000 kilograms.

The first planting was planned for the first half of 2019, Aurora initially said, and the facility was set to be completed during the second half of this year. Aurora told investors this week that it still expects to have at least six flower rooms totaling 238,000 square feet completed and operating by 2020.

“As global demand develops, or as Aurora’s market share in the global cannabis market increases, we will reactivate these projects,” the company said in a statement.

Aurora is the latest marijuana company to be forced to halt current projects due to cautionary spending tactics in response to current market conditions. HEXO (NYSE:HEXO,TSX:HEXO) also announced it will be suspending activities for the entirety of its facility in Niagara, Ontario, and 200,000 square feet of its facility in Gatineau, Quebec.

Aurora CFO Glen Ibbott said during a call with analysts last week that construction adjustments for both facilities are an effort to more closely align timelines with increasing demand for product.

“These adjustments will result in a significant decrease in our ongoing quarterly level of capital investment,” said Ibbott.

The construction freezes come after the company announced a drop of 24 percent in total net revenue in the latest quarter. It sank to C$75.2 million from C$98.9 million in Aurora’s fourth fiscal quarter of 2019.

Aurora attributed the loss to a decrease in revenue of non-wholesale cannabis and a slowdown of consumer cannabis sales as distributors worked through an inventory surplus over the summer. The firm also mentioned the slow retail store rollout as an inhibitor to revenue generation this quarter.

“The past few months have been challenging for the broader cannabis industry. Between issues of governance, evolving consumer demand and provincial retail bottlenecks, there has been no shortage of negative news,” said Chief Corporate Officer Cam Battley during the call.

He added that the company is still optimistic about the Canadian and international cannabis markets.

Aurora’s revenues missed the mark for analyst expectations. According to financial market data firm Refinitiv, analysts projected C$93.31 million in revenue for this past quarter.

The firm also reported a reduction in production cash cost to C$0.85 per gram, down from C$1.14 per gram in the previous quarter, as well as a cannabis yield of 41,436 kilograms, up 43 percent quarter-on-quarter from 29,034 kilograms.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

Centurion to acquire a Disruptive Water-Soluble Cannabinoid Technology Platform Delivering Rapid Onset, Increased Bioavailability, Premium Taste Profiles and Highly Competitive Cost Structure

Centurion Minerals Ltd. (TSXV: CTN) (FSE: XJCB) (“Centurion” or the “Company”) is pleased to announce that it has entered into an Amalgamation Agreement dated February 17, 2021 (the “Agreement”), with HAI Beverages Inc. (“HAI”), whereby Centurion will acquire 100% of the outstanding shares and assets of a wholly-owned subsidiary of HAI (“NewHAI) in exchange for common shares of Centurion (the “Acquisition” or “Transaction”). NewHAI holds all material assets of HAI and the Acquisition will constitute a reverse take-over (“RTO”) of the Company.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less